Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry

Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin

(2013) Ammar Majeed et al.   CIRCULATION

European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation

(2013) Hein Heidbuchel et al.   EUROPACE

Hospitalization for vitamin-K-antagonist-related bleeding: treatment patterns and outcome

(2013) K. Halbritter et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Risk of Thromboembolism, Recurrent Hemorrhage, and Death After Warfarin Therapy Interruption for Gastrointestinal Tract Bleeding

(2012) Daniel M. Witt et al.   ARCHIVES OF INTERNAL MEDICINE

Rates of hemorrhage during warfarin therapy for atrial fibrillation

(2012) T. Gomes et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Oral Anticoagulant Therapy

(2012) Walter Ageno et al.   CHEST

Anticoagulation-Related Intracranial Hemorrhages

(2012) Manoj K. Mittal et al.   Current Atherosclerosis Reports

Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

Poor Prognosis in Warfarin-Associated Intracranial Hemorrhage Despite Anticoagulation Reversal

(2012) Dar Dowlatshahi et al.   STROKE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists

(2011) Chiara Marchesi et al.   THROMBOSIS AND HAEMOSTASIS

Bleeding Complications With Dual Antiplatelet Therapy Among Patients With Stable Vascular Disease or Risk Factors for Vascular Disease

(2010) Peter B. Berger et al.   CIRCULATION

Oral Rivaroxaban for Symptomatic Venous Thromboembolism

(2010)   NEW ENGLAND JOURNAL OF MEDICINE